Categories
Market Updates

Global Autotransfusion Systems Market Size, Share 2020, Impressive Industry Growth Report 2026 – X herald

The global autotransfusion systems market is estimated to grow at a CAGR of 5.6% during the forecast period. Rising prevalence of CVD is primarily encouraging the demand for autotransfusion systems. As per the data published by the World Health Organization (WHO) in May 2017, CVDs are the number 1 cause of death globally. In 2016, an estimated 17.9 million people died from CVDs, which represents 31% of all global deaths. Of these deaths, 85% are due to stroke and heart attack. As per the American Heart Association, during the period, 2013 and 2016, 121.5 million American adults had some form of CVD.

In the US, coronary heart disease was the leading cause (43.2%) of deaths attributable to CVD in the US, followed by stroke (16.9%), high blood pressure (9.8%), heart failure (9.3%), diseases of the arteries (3.0%), and other CVD (17.7%). This, in turn, encourages the demand for cardiac surgeries to manage patients’ condition more effectively. Autologous transfusion of blood is an easy concept which supports the preservation of the red blood cells integrity, clotting factors, and platelets. As a result, quality blood without the incompatibility problem is administered to the patient. It eliminates the phase of cross-matching and thus, saving time and offer the benefits of instant availability of blood during the procedure.

To Request a Sample of our Report on Global Autotransfusion Systems Market:  https://www.omrglobal.com/request-sample/autotransfusion-systems-market

By preserving clotting factors, hemostasis is optimally achieved during the post bypass period. Using autotransfusion, the risk of alloimmunization or infection is totally removed. This blood carries a considerable volume of oxygen as it has a huge density of clean red blood cells. It encourages the reduction in bleeding from the drain in the post cardiopulmonary bypass period and decreases the need for utilization of blood products, including platelet-rich plasma (PRP) and fresh frozen plasma (FFP). In the cardiac procedure, autologous transfusion is considered as useful in faster recovery and short procedural duration.

To reduce the consumption of blood components, reduce mortality and morbidity and decrease hospital costs, autologous blood transfusion is expected to be integrated into medical practice. Further, the increasing number of organ transplants are further contributing to the market growth. as per the Global Observatory on Donation and Transplantation (GODT), in 2017, the number of organs transplanted was 139,024, which increased to 7.3% over 2015. The emerging demand for organ transplantation procedure is leading to increasing demand for autologous blood transfusion for patients’ blood management during the organ transplantation procedure.  This, in turn, will likely present an enormous opportunity for the growth of the global autotransfusion systems market.

(Get 15% Discount on Buying this Report)

A full Report of Global Autotransfusion Systems Market is Available at:  https://www.omrglobal.com/industry-reports/autotransfusion-systems-market

Autotransfusion Systems Market Segmentation

By Application

  • Orthopedic Surgery
  • Cardiac Surgery
  • Trauma Procedures
  • Organ Transplantation
  • Other Procedures

By Type

  • Autotransfusion Products
  • Accessories

Autotransfusion Systems Market – Segment by Region 

North America           

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific    

Rest of Asia-Pacific

Company Profiles

  • Advancis Surgical
  • Atrium Medical Corp.
  • Braun Melsungen AG
  • Becton, Dickinson and Co.
  • Beijing ZKSK Technology Co., Ltd.
  • BraileBiomédica
  • Brightwake Ltd.
  • Ecomed Solutions, LLC
  • Fresenius KabiAG
  • Gen World Medical Devices
  • Getinge AB
  • Haemonetics Corp.
  • LivaNova PLC
  • Medtronic plc
  • Palex Medical SA
  • p.a.
  • SARSTEDT AG & Co. KG
  • Stryker Corp.
  • Teleflex Inc.
  • Terumo Corp.
  • Zimmer Biomet Holdings, Inc.

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/autotransfusion-systems-market

 

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Press Release Distributed by Xherald

Leave a Reply

Your email address will not be published. Required fields are marked *